Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: Differential association with membrane lipid raft microdomains

Journal of Lipid Research

Volumn 52, Issue 4, 2011, Pages 618-634

  Betz, Josefine ^a   Bielaszewska, Martina ^a   Thies, Andrea ^a   Humpf, Hans Ulrich ^a   Dreisewerd, Klaus ^a   Karch, Helge ^a   Kim, Kwang S ^b   Friedrich, Alexander W ^a   Müthing, Johannes ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Caveolae; Caveolin 1; DRM; Flotillin 2; Gb3Cer; Gb4Cer; Glycolipid

Indexed keywords

ANTIBODY; CHOLESTEROL; DETERGENT; FATTY ACID; GLOBOTETRAOSYLCERAMIDE; GLOBOTRIAOSYLCERAMIDE; GLYCOSPHINGOLIPID; GLYCOSPHINGOLIPID RECEPTOR; METHYL BETA CYCLODEXTRIN; RECEPTOR; SHIGA TOXIN; SPHINGOSINE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN BLOOD VESSEL; CELL MEMBRANE RESISTANCE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEPLETION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFRARED MATRIX ASSISTED LASER DESORPTION IONIZATION MASS SPECTROMETRY; LIPID RAFT; MASS SPECTROMETRY; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; RECEPTOR BINDING; THIN LAYER CHROMATOGRAPHY;

BLOTTING, WESTERN; CAVEOLIN 1; CELL LINE; CHOLESTEROL; CHROMATOGRAPHY, THIN LAYER; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOTHELIAL CELLS; GLYCOSPHINGOLIPIDS; HUMANS; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRIHEXOSYLCERAMIDES;

EID: 79953313811     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M010819     Document Type: Article

References (84)

1. Lingwood, D., and K. Simons. 2010. Lipid rafts as a membrane-organizing principle. Science. 327: 46-50.
2. Pike, L. J. 2003. Lipid rafts: bringing order to chaos. J. Lipid Res. 44: 655-667. (Pubitemid 37279667)
3. Bauer, M., and L. Pelkmans. 2006. A new paradigm for membrane-organizing and-shaping scaffolds. FEBS Lett. 580: 5559-5564. (Pubitemid 44465913)
4. Yu, C., M. Alterman, and R. T. Dobrowsky. 2005. Ceramide displaces cholesterol from lipid rafts and decreases the association of the cholesterol binding protein caveolin-1. J. Lipid Res. 46: 1678-1691.
5. Rothberg, K. G., J. E. Heuser, W. C. Donzell, Y-S. Ying, J. R. Glenney, and R. G. Anderson. 1992. Caveolin, a protein component of caveolae membrane coats. Cell. 68: 673-682.
6. Glebov, O. O., N. A. Bright, and B. J. Nichols. 2006. Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat. Cell Biol. 8: 46-54.
7. Fielding, C. J., and P. E. Fielding. 1997. Intracellular cholesterol transport. J. Lipid Res. 38: 1503-1521.
8. Gargalovic, P., and L. Dory. 2003. Caveolins and macrophage lipid metabolism. J. Lipid Res. 44: 11-21. (Pubitemid 36114765)
9. Parton, R. G., and A. A. Richards. 2003. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic. 4: 724-738.
10. Zheng, Y. Z., and L. J. Foster. 2009. Contributions of quantitative proteomics to understanding membrane microdomains. J. Lipid Res. 50: 1976-1985.
11. Sprenger, R. R., D. Speijer, J. W. Back, C. G. de Koster, H. Pannekoek, and A. J. G. Horrevoets. 2004. Comparative proteomics of human endothelial cell caveolae and rafts using two-dimensional gel electrophoresis and mass spectrometry. Electrophoresis. 25: 156-172.
12. Karsan, A., J. Blonder, J. Law, E. Yaquian, D. A. Lucas, T. P. Conrads, and T. Veenstra. 2005. Proteomic analysis of lipid microdomains from lipopolysaccharide-activated human endothelial cells. J. Proteome Res. 4: 349-357. (Pubitemid 40548139)
13. Gupta, G., and A. Surolia. 2010. Glycosphingolipids in microdomain formation and their spatial organization. FEBS Lett. 584: 1634-1641.
14. Levery, S. B. 2005. Glycosphingolipid structural analysis and glycosphingolipidomics. Methods Enzymol. 405: 300-369. (Pubitemid 43081964)
15. Müthing, J., and U. Distler. 2010. Advances on the compositional analysis of glycosphingolipids combining thin-layer chromatography with mass spectrometry. Mass Spectrom. Rev. 29: 425-479.
16. Lopez, P. H., and R. L. Schnaar. 2009. Gangliosides in cell recognition and membrane protein regulation. Curr. Opin. Struct. Biol. 19: 549-557.
17. Miller-Podraza, H., L. Johansson, P. Johansson, T. Larsson, M. Matrosovich, and K-A. Karlsson. 2000. A strain of human influenza A virus binds to extended but not short gangliosides as assayed by thin-layer chromatography overlay. Glycobiology. 10: 975-982.
18. Campanero-Rhodes, M. A., A. Smith, W. Chai, S. Sonnino, L. Mauri, R. A. Childs, Y. Zhang, H. Ewers, A. Helenius, A. Imberty, et al. 2007. N-Glycolyl GM1 ganglioside as a receptor for simian virus 40. J. Virol. 81: 12846-12858. (Pubitemid 350156922)
19. Karlsson, K-A. 1989. Animal glycosphingolipids as membrane attachment sites for bacteria. Annu. Rev. Biochem. 58: 309-350.
20. Miller-Podraza, H., P. Johansson, J. Ångström, T. Larsson, M. Longard, and K-A. Karlsson. 2004. Studies on gangliosides with affinity for Helicobacter pylori: binding to natural and chemically modified structures. Glycobiology. 14: 205-217. (Pubitemid 38331911)
21. Lingwood, C. A., H. Law, S. Richardson, M. Petric, J. L. Brunton, S. De Grandis, and M. Karmali. 1987. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J. Biol. Chem. 262: 8834-8839.
22. Müthing, J., C. H. Schweppe, H. Karch, and A. W. Friedrich. 2009. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb. Haemost. 101: 252-264.
23. Merrill, A. H., Jr., M. D. Wang, M. Park, and M. C. Sullards. 2007. (Glyco)sphingolipidology: an amazing challenge and opportunity for systems biology. Trends Biochem. Sci. 32: 457-468.
24. Merrill, A. H., Jr., T. H. Stokes, A. Momin, H. Park, B. J. Portz, S. Kelly, E. Wang, M. C. Sullards, and M. D. Wang. 2009. Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease. J. Lipid Res. 50: S97-S102.
25. Li, Y., P. Thapa, D. Hawke, Y. Kondo, K. Furukawa, K. Furukawa, F-F. Hsu, D. Adlercreutz, J. Weadge, M. M. Palcic, et al. 2009. Immunologic glycosphingolipidomics and NKT cell development in mouse thymus. J. Proteome Res. 8: 2740-2751.
26. Raa, H., S. Grimmer, D. Schwudke, J. Bergan, S. Wälchli, T. Skotland, A. Shevchenko, and K. Sandvig. 2009. Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin. Traffic. 10: 868-882.
27. Li, Y., S. Teneberg, P. Thapa, A. Bendelac, S. B. Levery, and D. Zhou. 2008. Sensitive detection of isoglobo and globo series tetraglycosylceramides in human thymus by ion trap mass spectrometry. Glycobiology. 18: 158-165. (Pubitemid 351168254)
28. Li, Y., D. Zhou, C. Xia, P. G. Wang, and S. B. Levery. 2008. Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry. Glycobiology. 18: 166-176.
29. Shaner, R. L., J. C. Allegood, H. Park, E. Wang, S. Kelly, C. A. Haynes, M. C. Sullards, and A. H. Merrill, Jr. 2009. Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J. Lipid Res. 50: 1692-1707.
30. Li, Y., E. Arigi, H. Eichert, and S. B. Levery. 2010. Mass spectrometry of fluorocarbon-labeled glycosphingolipids. J. Mass Spectrom. 45: 504-519.
31. Fuchs, B., R. Süss, and J. Schiller. 2010. An update of MALDI-TOF mass spectrometry in lipid research. Prog. Lipid Res. 49: 450-475.
32. Pike, L. J. 2009. The challenge of lipid rafts. J. Lipid Res. 50: S323-S328.
33. Gillard, B. K., M. A. Jones, and D. M. Marcus. 1987. Glycosphingolipids of human umbilical vein endothelial cells and smooth muscle cells. Arch. Biochem. Biophys. 256: 435-445.
34. Müthing, J., S. Duvar, D. Heitmann, F. G. Hanisch, U. Neumann, G. Lochnit, R. Geyer, and J. Peter-Katalinić. 1999. Isolation and structural characterization of glycosphingolipids of in vitro propagated human umbilical vein endothelial cells. Glycobiology. 9: 459-468. (Pubitemid 29240343)
35. Okuda, T., S-I. Nakakita, and K-I. Nakayama. 2010. Structural characterization and dynamics of globotetraosylceramide in vascular endothelial cells under TNF-α stimulation. Glycoconj. J. 27: 287-296.
36. Bielaszewska, M., and H. Karch. 2005. Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium. Thromb. Haemost. 94: 312-318.
37. Karch, H., P. I. Tarr, and M. Bielaszewska. 2005. Enterohaemorrhagic Escherichia coli in human medicine. Int. J. Med. Microbiol. 295: 405-418.
38. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shigatoxin- producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 365: 1073-1086. (Pubitemid 40386785)
39. Hurley, B. P., C. M. Thorpe, and D. W. Acheson. 2001. Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect. Immun. 69: 6148-6155.
40. Brigotti, M., D. Carnicelli, E. Ravanelli, S. Barbieri, F. Ricci, A. Bontadini, A. E. Tozzi, G. Scavia, A. Caprioli, and P. L. Tazzari. 2008. Interactions between Shiga toxins and human polymorphonuclear leukocytes. J. Leukoc. Biol. 84: 1019-1027.
41. Brigotti, M., P. L. Tazzari, E. Ravanelli, D. Carnicelli, S. Barbieri, L. Rocchi, V. Arfilli, G. Scavia, F. Ricci, A. Bontadini, et al. 2010. Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration. J. Leukoc. Biol. 88: 201-210.
42. Sandvig, K., Ø. Garred, K. Prydz, J. V. Kozlov, S. H. Hansen, and B. van Deurs. 1992. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature. 358: 510-512.
43. Sandvig, K. 2001. Shiga toxins. Toxicon. 39: 1629-1635. (Pubitemid 32786996)
44. Sandvig, K., M. L. Torgersen, N. Engedal, T. Skotland, and T-G. Iversen. 2010. Protein toxins from plants and bacteria: probes for intracellular transport and tools in medicine. FEBS Lett. 584: 2626-2634.
45. Kovbasnjuk, O., M. Edidin, and M. Donowitz. 2001. Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells. J. Cell Sci. 114: 4025-4031. (Pubitemid 33115023)
46. Hanashima, T., M. Miyake, K. Yahiro, Y. Iwamaru, A. Ando, N. Morinaga, and M. Noda. 2008. Effect of Gb3 in lipid rafts in resistance to Shiga-like toxin of mutant Vero cells. Microb. Pathog. 45: 124-133.
47. Falguières, T., F. Mallard, C. Baron, D. Hanau, C. Lingwood, B. Gould, J. Salamero, and L. Johannes. 2001. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell. 12: 2453-2468.
48. Falguières, T., W. Römer, M. Amessou, C. Afonso, C. Wolf, J. C. Tabet, C. Lamaze, and L. Johannes. 2006. Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells. FEBS J. 273: 5205-5218. (Pubitemid 44673308)
49. Smith, D. C., D. J. Sillence, T. Falguières, R. M. Jarvis, L. Johannes, J. M. Lord, F. M. Platt, and L. M. Roberts. 2006. The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol. Biol. Cell. 17: 1375-1387.
50. Fujinaga, Y., A. A. Wolf, C. Rodighiero, H. Wheeler, B. Tsai, L. Allen, M. G. Jobling, T. Rapoport, R. K. Holmes, and W. I. Lencer. 2003. Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulum. Mol. Biol. Cell. 14: 4783-4793.
51. Lencer, W. I., and D. Saslowsky. 2005. Raft trafficking of AB 5 subunit bacterial toxins. Biochim. Biophys. Acta. 1746: 314-321.
52. Schweppe, C. H., M. Bielaszewska, G. Pohlentz, A. W. Friedrich, H. Büntemeyer, M. A. Schmidt, K. S. Kim, J. Peter-Katalinić, H. Karch, and J. Müthing. 2008. Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/CD77 receptor expression with differential Shiga toxin 1 cytotoxicity. Glycoconj. J. 25: 291-304.
53. Stins, M. F., F. Gilles, and K. S. Kim. 1997. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J. Neuroimmunol. 76: 81-90.
54. Edgell, C-J. S., C. C. McDonald, and J. B. Graham. 1983. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA. 80: 3734-3737.
55. Ledeen, R. W., and R. K. Yu. 1982. Gangliosides: structure, isolation, and analysis. Methods Enzymol. 83: 139-191.
56. Müthing, J., U. Maurer, K. Šoštarić, U. Neumann, H. Brandt, S. Duvar, J. Peter-Katalinić, and S. Weber-Schürholz. 1994. Different distributions of glycosphingolipids in mouse and rabbit skeletal muscle demonstrated by biochemical and immunohistological analyses. J. Biochem. 115: 248-256. (Pubitemid 24060156)
57. Meisen, I., A. W. Friedrich, H. Karch, U. Witting, J. Peter-Katalinić, and J. Müthing. 2005. Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high-and low-affinity binding ligands of Shiga toxin 1. Rapid Commun. Mass Spectrom. 19: 3659-3665.
58. Schweppe, C. H., P. Hoffmann, J-R. Nofer, G. Pohlentz, M. Mormann, H. Karch, A. W. Friedrich, and J. Müthing. 2010. Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors. J. Lipid Res. 51: 2282-2294.
59. Distler, U., J. Souady, M. Hülsewig, I. Drmić-Hofman, J. Haier, A. W. Friedrich, H. Karch, N. Senninger, K. Dreisewerd, S. Berkenkamp, et al. 2009. Shiga toxin receptor Gb3Cer/CD77: tumor association and promising therapeutic target in pancreas and colon cancer. PLoS ONE. 4: e6813.
60. Hoffmann, P., M. Hülsewig, S. Duvar, H. Ziehr, M. Mormann, J. Peter-Katalinić, A. W. Friedrich, H. Karch, and J. Müthing. 2010. On the structural diversity of Shiga toxin glycosphingolipid receptors in lymphoid and myeloid cells determined by nanoelectrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 24: 2295-2304.
61. Chester, M. A. 1998. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids. Recommendations 1997. Eur. J. Biochem. 257: 293-298.
62. Müthing, J. 1998. TLC in structure and recognition studies of glycosphingolipids. In Methods in Molecular Biology. E. F. Hounsell, editor. Humana Press Inc., Totawa, NJ. 183-195.
63. Goswami, S. K., and C. F. Frey. 1970. Manganous chloride spray reagent for cholesterol and bile acids on thin-layer chromatograms. J. Chromatogr. A. 53: 389-390.
64. Distler, U., M. Hülsewig, J. Souady, K. Dreisewerd, J. Haier, N. Senninger, A. W. Friedrich, H. Karch, F. Hillenkamp, S. Berkenkamp, et al. 2008. Matching IR-MALDI-o-TOF mass spectrometry with the TLC overlay binding assay and its clinical application for tracing tumor-associated glycosphingolipids in hepatocellular and pancreatic cancer. Anal. Chem. 80: 1835-1846.
65. Brown, D. A., and J. K. Rose. 1992. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell. 68: 533-544.
66. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
67. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
68. Dreisewerd, K., J. Müthing, A. Rohlfing, I. Meisen, Ž. Vukelić, J. Peter-Katalinić, F. Hillenkamp, and S. Berkenkamp. 2005. Analysis of gangliosides directly from thin-layer chromatography plates by infrared matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry with a glycerol matrix. Anal. Chem. 77: 4098-4107.
69. Roitbak, T., Z. Surviladze, R. Tikkanen, and A. Wandinger-Ness. 2005. A polycystin multiprotein complex constitutes a cholesterol-containing signalling microdomain in human kidney epithelia. Biochem. J. 392: 29-38. (Pubitemid 41689398)
70. Trajkovic, K., C. Hsu, S. Chiantia, L. Rajendran, D. Wenzel, F. Wieland, P. Schwille, B. Brügger, and M. Simons. 2008. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 319: 1244-1247. (Pubitemid 351323020)
71. Cohly, H., J. Stephens, A. Markhov, M. Angel, W. Campbell, K. Ndebele, and J. Jenkins. 2001. Cell culture conditions affect LPS inducibility of the inflammatory mediators in J774A.1 murine macrophages. Immunol. Invest. 30: 1-15.
72. Lingwood, D., and K. Simons. 2007. Detergent resistance as a tool in membrane research. Nat. Protoc. 2: 2159-2165.
73. Bauwens, A., M. Bielaszewska, B. Kemper, P. Langehanenberg, G. von Bally, R. Reichelt, D. Mulac, H-U. Humpf, A. W. Friedrich, K. S. Kim, et al. Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macrovascular endothelial cells. Thromb. Haemost. Epub ahead of print. December 6, 2010; doi: 10.1160/TH10-02-0140.
74. Sandvig, K., J. Bergan, A-B. Dyve, T. Skotland, and M. L. Torgersen. 2010. Endocytosis and retrograde transport of Shiga toxin. Toxicon. 56: 1181-1185.
75. Pust, S., A. B. Dyve, M. L. Torgersen, B. van Deurs, and K. Sandvig. 2010. Interplay between toxin transport and flotillin locolaization. PLoS ONE. 5: e8844.
76. Hoey, D. E. E., L. Sharp, C. Currie, C. A. Lingwood, D. L. Gally, and D. G. E. Smith. 2003. Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity. Cell. Microbiol. 5: 85-97.
77. Tam, P., R. Mahfoud, A. Nutikka, A. A. Khine, B. Binnington, P. Paroutis, and C. Lingwood. 2008. Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies. J. Cell. Physiol. 216: 750-763.
78. Khan, F., F. Proulx, and C. A. Lingwood. 2009. Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology. Kidney Int. 75: 1209-1216.
79. Lingwood, C. A., A. Manis, R. Mahfoud, F. Khan, B. Binnington, and M. Mylvaganam. 2010. New aspects of the regulation of glycosphingolipid receptor function. Chem. Phys. Lipids. 163: 27-35.
80. Lingwood, C. A., B. Binnington, A. Manis, and D. R. Branch. 2010. Globotriaosyl ceramide receptor function-where membrane structure and pathology intersect. FEBS Lett. 584: 1879-1886.
81. Mahfoud, R., A. Manis, and C. A. Lingwood. 2009. Fatty acid-dependent globotriaosyl ceramide receptor function in detergent resistant model membranes. J. Lipid Res. 50: 1744-1755.
82. Warnier, M., W. Römer, J. Geelen, J. Lesieur, M. Amessou, L. van den Heuvel, L. Monnens, and L. Johannes. 2006. Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells. Kidney Int. 70: 2085-2091.
83. Cheng, Z-J., R. D. Singh, D. K. Sharma, E. L. Holicky, K. Hanada, D. L. Marks, and R. E. Pagano. 2006. Distinct mechanisms of clathrin-independent endocytosis have unique sphingolipid requirements. Mol. Biol. Cell. 17: 3197-3210.
84. Römer, W., L. Berland, V. Chambon, K. Gaus, B. Windschiegl, D. Tenza, M. R. Aly, V. Fraisier, J-C. Florent, D. Perrais, et al. 2007. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature. 450: 670-675. (Pubitemid 350207679)